Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
bioMérieux S.A. stock logo
BMXMF
bioMérieux
$105.69
$109.32
$90.23
$115.25
N/A0.8754 shsN/A
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
$7.08
+1.7%
$6.91
$4.14
$9.37
$2.80B1.421.51 million shs558,378 shs
Merck KGaA stock logo
MKGAF
Merck KGaA
$165.33
+4.4%
$169.01
$143.46
$186.41
$21.37B0.931,011 shs1,092 shs
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$13.33
-2.9%
$15.17
$12.85
$30.41
$2.26B0.944.76 million shs6.84 million shs
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
bioMérieux S.A. stock logo
BMXMF
bioMérieux
0.00%-4.78%-2.63%-5.63%-3.04%
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
-0.14%+7.08%-1.56%+6.91%+26.78%
Merck KGaA stock logo
MKGAF
Merck KGaA
-1.33%-0.24%-8.53%-2.11%-10.02%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-0.07%+4.57%-8.92%-32.54%-48.17%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
bioMérieux S.A. stock logo
BMXMF
bioMérieux
N/AN/AN/AN/AN/AN/AN/AN/A
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
2.6467 of 5 stars
3.20.00.00.02.41.71.9
Merck KGaA stock logo
MKGAF
Merck KGaA
N/AN/AN/AN/AN/AN/AN/AN/A
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
3.2867 of 5 stars
4.21.00.00.03.02.51.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
bioMérieux S.A. stock logo
BMXMF
bioMérieux
3.00
BuyN/AN/A
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
2.47
Hold$8.7823.98% Upside
Merck KGaA stock logo
MKGAF
Merck KGaA
N/AN/AN/AN/A
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
2.46
Hold$22.2366.77% Upside

Current Analyst Ratings

Latest TDOC, GDRX, BMXMF, and MKGAF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/10/2024
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Weight ➝ Overweight$9.00
4/5/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
3/25/2024
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$7.50 ➝ $10.00
3/6/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$23.00 ➝ $17.00
3/1/2024
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$6.00 ➝ $7.50
3/1/2024
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$5.00 ➝ $8.00
3/1/2024
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$7.00 ➝ $8.00
3/1/2024
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$6.50 ➝ $7.50
3/1/2024
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$12.00 ➝ $14.00
3/1/2024
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$7.50 ➝ $8.00
3/1/2024
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$8.00 ➝ $9.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
bioMérieux S.A. stock logo
BMXMF
bioMérieux
$3.98BN/A$5.90 per share17.92$32.43 per shareN/A
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
$750.27M3.73$0.42 per share16.88$1.93 per share3.67
Merck KGaA stock logo
MKGAF
Merck KGaA
$22.72B0.94$53.68 per share3.08$212.00 per share0.78
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$2.60B0.87$0.79 per share16.93$14.05 per share0.95

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
bioMérieux S.A. stock logo
BMXMF
bioMérieux
$387MN/A0.0021.01N/AN/AN/AN/AN/A
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
-$8.87M-$0.02N/A22.843.82-1.18%2.45%1.25%5/9/2024 (Confirmed)
Merck KGaA stock logo
MKGAF
Merck KGaA
$3.06B$7.0323.5216.39N/A13.47%12.18%6.72%N/A
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$220.37M-$1.34N/AN/AN/A-8.47%-9.22%-4.89%4/25/2024 (Confirmed)

Latest TDOC, GDRX, BMXMF, and MKGAF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
$0.0870N/A-$0.0870N/AN/AN/A  
4/25/2024N/A
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$0.47-$0.49-$0.02N/A$637.31 million$646.13 million  
3/7/2024Q4 2023
Merck KGaA stock logo
MKGAF
Merck KGaA
$2.15$1.99-$0.16$2.53$5.58 billion$5.63 billion
2/29/2024Q4 2023
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
$0.02$0.02N/A$0.10$195.59 million$196.64 million
2/20/2024Q4 2023
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$0.22-$0.17+$0.05-$0.17$670.79 million$660.50 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
bioMérieux S.A. stock logo
BMXMF
bioMérieux
N/AN/AN/AN/AN/A
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
N/AN/AN/AN/AN/A
Merck KGaA stock logo
MKGAF
Merck KGaA
N/AN/AN/AN/AN/A
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
bioMérieux S.A. stock logo
BMXMF
bioMérieux
N/AN/AN/A
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
0.85
7.12
7.12
Merck KGaA stock logo
MKGAF
Merck KGaA
0.35
1.42
0.89
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
0.66
3.54
3.47

Ownership

Institutional Ownership

CompanyInstitutional Ownership
bioMérieux S.A. stock logo
BMXMF
bioMérieux
N/A
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
63.77%
Merck KGaA stock logo
MKGAF
Merck KGaA
0.10%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
76.82%

Insider Ownership

CompanyInsider Ownership
bioMérieux S.A. stock logo
BMXMF
bioMérieux
N/A
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
1.37%
Merck KGaA stock logo
MKGAF
Merck KGaA
N/A
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
1.63%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
bioMérieux S.A. stock logo
BMXMF
bioMérieux
13,800N/AN/ANot Optionable
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
694395.00 million389.59 millionOptionable
Merck KGaA stock logo
MKGAF
Merck KGaA
62,908129.24 millionN/ANot Optionable
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
5,600169.31 million166.55 millionOptionable

TDOC, GDRX, BMXMF, and MKGAF Headlines

SourceHeadline
Teladoc (TDOC) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesTeladoc (TDOC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
zacks.com - April 25 at 7:01 PM
Teladoc (TDOC) Reports Q1 Loss, Tops Revenue EstimatesTeladoc (TDOC) Reports Q1 Loss, Tops Revenue Estimates
zacks.com - April 25 at 6:30 PM
Teladoc Health (NYSE:TDOC) Issues Q2 2024 Earnings GuidanceTeladoc Health (NYSE:TDOC) Issues Q2 2024 Earnings Guidance
marketbeat.com - April 25 at 5:47 PM
Teladoc Health Reports First Quarter 2024 ResultsTeladoc Health Reports First Quarter 2024 Results
globenewswire.com - April 25 at 4:05 PM
Maintaining Hold on Teladoc Amid Reduced Competition and Stable Market PositionMaintaining Hold on Teladoc Amid Reduced Competition and Stable Market Position
markets.businessinsider.com - April 25 at 2:51 PM
Teladoc (TDOC) stock price analysis and the fall from graceTeladoc (TDOC) stock price analysis and the fall from grace
invezz.com - April 25 at 9:51 AM
Earnings To Watch: Teladoc (TDOC) Reports Q1 Results TomorrowEarnings To Watch: Teladoc (TDOC) Reports Q1 Results Tomorrow
finance.yahoo.com - April 24 at 7:45 AM
Can Higher Visits Soften Cost Blow for Teladoc (TDOC) in Q1?Can Higher Visits Soften Cost Blow for Teladoc (TDOC) in Q1?
zacks.com - April 23 at 12:36 PM
Teladoc Health, Inc. (NYSE:TDOC) Shares Sold by Federated Hermes Inc.Teladoc Health, Inc. (NYSE:TDOC) Shares Sold by Federated Hermes Inc.
marketbeat.com - April 23 at 5:36 AM
ATTENTION Teladoc Health, Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your RightsATTENTION Teladoc Health, Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights
accesswire.com - April 22 at 7:40 AM
International Assets Investment Management LLC Acquires 106,069 Shares of Teladoc Health, Inc. (NYSE:TDOC)International Assets Investment Management LLC Acquires 106,069 Shares of Teladoc Health, Inc. (NYSE:TDOC)
marketbeat.com - April 20 at 4:42 AM
Should You Buy This Beaten-Down Stock?Should You Buy This Beaten-Down Stock?
fool.com - April 19 at 9:45 AM
TDOC STOCK ALERT: Levi & Korsinsky Notifies Teladoc Health, Inc. Investors of an Ongoing InvestigationTDOC STOCK ALERT: Levi & Korsinsky Notifies Teladoc Health, Inc. Investors of an Ongoing Investigation
accesswire.com - April 19 at 7:35 AM
Analysts Estimate Teladoc (TDOC) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Teladoc (TDOC) to Report a Decline in Earnings: What to Look Out for
zacks.com - April 18 at 11:06 AM
Levi & Korsinsky Reminds Teladoc Investors of the Ongoing Investigation into Potential Violations of Securities Laws - TDOCLevi & Korsinsky Reminds Teladoc Investors of the Ongoing Investigation into Potential Violations of Securities Laws - TDOC
accesswire.com - April 18 at 7:30 AM
Insider Selling: Teladoc Health, Inc. (NYSE:TDOC) Insider Sells 1,000 Shares of StockInsider Selling: Teladoc Health, Inc. (NYSE:TDOC) Insider Sells 1,000 Shares of Stock
insidertrades.com - April 18 at 7:10 AM
Teladoc Health (TDOC) Scheduled to Post Earnings on ThursdayTeladoc Health (TDOC) Scheduled to Post Earnings on Thursday
americanbankingnews.com - April 18 at 3:28 AM
Teladoc (TDOC) Increases Despite Market Slip: Heres What You Need to KnowTeladoc (TDOC) Increases Despite Market Slip: Here's What You Need to Know
zacks.com - April 17 at 7:21 PM
Daniel Trencher Sells 1,000 Shares of Teladoc Health, Inc. (NYSE:TDOC) StockDaniel Trencher Sells 1,000 Shares of Teladoc Health, Inc. (NYSE:TDOC) Stock
marketbeat.com - April 17 at 6:51 PM
Teladoc: Improving Business Trends (Rating Upgrade)Teladoc: Improving Business Trends (Rating Upgrade)
seekingalpha.com - April 17 at 5:03 AM
The Cathie Wood Stock Shuffle: 4 Names Shes Loving, 3 Shes LeavingThe Cathie Wood Stock Shuffle: 4 Names She's Loving, 3 She's Leaving
investorplace.com - April 16 at 2:47 PM
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just BoughtCathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
fool.com - April 16 at 11:55 AM
Shareholders that lost money on Teladoc Health, Inc.(TDOC) should contact Levi & Korsinsky about Securities Fraud Investigation - TDOCShareholders that lost money on Teladoc Health, Inc.(TDOC) should contact Levi & Korsinsky about Securities Fraud Investigation - TDOC
accesswire.com - April 16 at 7:30 AM
Sumitomo Mitsui Trust Holdings Inc. Sells 212,972 Shares of Teladoc Health, Inc. (NYSE:TDOC)Sumitomo Mitsui Trust Holdings Inc. Sells 212,972 Shares of Teladoc Health, Inc. (NYSE:TDOC)
marketbeat.com - April 16 at 7:14 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

bioMérieux logo

bioMérieux

OTCMKTS:BMXMF
bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries. It also provides a suite of software products and services that collect, analyze, and merge various sources of data to make decisions under the BIOMÉRIEUX VISION SUITE name; designs, manufactures, and maintains instruments and software; and designs and manufactures reagents for in vitro diagnostic tests. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.
GoodRx logo

GoodRx

NASDAQ:GDRX
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.
Merck KGaA logo

Merck KGaA

OTCMKTS:MKGAF
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies. Its Healthcare segment discovers, develops, manufacturers, and markets prescription drugs and biopharmaceuticals for the treatment of oncology, neurology and immunology, fertility, endocrinology, as well as cardiovascular, diabetes, thyroid disorders, and multiple sclerosis; general medicines; and injection device and disease monitoring software. The Electronics segment supplies materials for the semiconductor and display industries and surface design, such as delivery systems and services, as well as surface solutions, including cosmetics, effect pigments, and functional solutions. In addition, it has in-licensing agreement with Debiopharm International SA for developing and commercializing drug candidates for the treatment of head and neck cancer; Jiangsu Hengrui Pharmaceuticals Co. Ltd. for developing, manufacturing, and commercializing drug candidates for the treatment of metastatic colorectal cancer; and Abbisko Therapeutics Co. Ltd. for developing and commercializing of drug candidates for the treatment of tenosynovial giant cell tumor, as well as license and collaboration agreement with Merck KGaA to discover two targeted protein degraders against critical oncogenic proteins. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KGaA.
Teladoc Health logo

Teladoc Health

NYSE:TDOC
Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.